The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1159308910 11593089 10 F 20150710 20160830 20151005 20160909 EXP JP-AMGEN-JPNCT2015096591 AMGEN 70.00 YR E F Y 48.40000 KG 20160909 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1159308910 11593089 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WEEKS 125147 6 MG/KG SOLUTION FOR INJECTION QOW
1159308910 11593089 2 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WEEKS U 0 400 MG/M**2 QOW
1159308910 11593089 3 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS U 0 2400 MG/M**2 QOW
1159308910 11593089 4 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS U 0 85 MG/M**2 QOW
1159308910 11593089 5 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 1200 MG/M2 U 0 200 MG/M**2 QOW
1159308910 11593089 6 C HIRUDOID /00723701/ PENTOSAN POLYSULFATE SODIUM 1 Transdermal UNK U 0
1159308910 11593089 7 C LOCOID HYDROCORTISONE BUTYRATE 1 Transdermal UNK U 0
1159308910 11593089 8 C ANTEBATE BETAMETHASONE DIPROPIONATE 1 Transdermal UNK U 0
1159308910 11593089 9 C DECADRON DEXAMETHASONE 1 Oral 0.5 MG, BID 4 MG U 0 .5 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1159308910 11593089 1 Colon cancer
1159308910 11593089 2 Colon cancer
1159308910 11593089 4 Colon cancer
1159308910 11593089 5 Colon cancer
1159308910 11593089 6 Prophylaxis
1159308910 11593089 7 Prophylaxis
1159308910 11593089 8 Prophylaxis
1159308910 11593089 9 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
1159308910 11593089 OT
1159308910 11593089 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1159308910 11593089 Abdominal pain upper
1159308910 11593089 Decreased appetite
1159308910 11593089 Dermatitis bullous
1159308910 11593089 Dysgeusia
1159308910 11593089 Fatigue
1159308910 11593089 Nausea
1159308910 11593089 Neuropathy peripheral
1159308910 11593089 Neutrophil count decreased
1159308910 11593089 Pancytopenia
1159308910 11593089 Platelet count decreased
1159308910 11593089 Rash
1159308910 11593089 Skin disorder
1159308910 11593089 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1159308910 11593089 1 20150709 0
1159308910 11593089 2 20150709 0
1159308910 11593089 3 20150709 0
1159308910 11593089 4 20150709 0
1159308910 11593089 5 20150709 20150917 0
1159308910 11593089 6 20150708 0
1159308910 11593089 7 20150708 0
1159308910 11593089 8 20150708 0
1159308910 11593089 9 20150918 20150921 0